Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription 10.06.2024 1 BMC Neurol 1 Brain Res 1 J Neural Transm (Vienna) 1 Mov Disord 1 Neurobiol Dis 2 Neurology 1 Neuron 1 Neuroscience 1 Proc Natl Acad Sci U S A 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. MOES HR, Buskens E, van Laar T
   Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries".
   BMC Neurol. 2024;24:189.
   PubMed         Abstract available
   
   

   
   Brain Res

2. SHAH S, Pushpa Tryphena K, Singh G, Kulkarni A, et al
   Neuroprotective role of Carvacrol via Nrf2/HO-1/NLRP3 axis in Rotenone-induced PD mice model.
   Brain Res. 2024;1836:148954.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

3. ARCE-SILLAS A, Alvarez-Luquin DD, Leyva-Hernandez J, Montes-Moratilla E, et al
   Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson's disease: a 1-year observational study.
   J Neural Transm (Vienna). 2024 Jun 1. doi: 10.1007/s00702-024-02790.
   PubMed         Abstract available
   
   

   
   Mov Disord

4. JENSEN I, Heine J, Ruf VC, Compta Y, et al
   Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria.
   Mov Disord. 2024 Jun 7. doi: 10.1002/mds.29879.
   PubMed         Abstract available
   
   

   
   Neurobiol Dis

5. YAN S, Lu J, Duan B, Zhu H, et al
   Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps.
   Neurobiol Dis. 2024;198:106549.
   PubMed         Abstract available
   
   

   
   Neurology

6. KIM S, Na HK, Sun Y, Yoon YJ, et al
   Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease.
   Neurology. 2024;102:e209483.
   PubMed         Abstract available
   
   
7. LE HERON C, Horne KL, MacAskill MR, Livingstone L, et al
   Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.
   Neurology. 2024;102:e209301.
   PubMed         Abstract available
   
   

   
   Neuron

8. ENDO H, Ono M, Takado Y, Matsuoka K, et al
   Imaging alpha-synuclein pathologies in animal models and patients with Parkinson's and related diseases.
   Neuron. 2024 May 27:S0896-6273(24)00332-5. doi: 10.1016/j.neuron.2024.
   PubMed         Abstract available
   
   

   
   Neuroscience

9. KUMARI S, Rana B, Senthil Kumaran S, Chaudhary S, et al
   Gray matter atrophy in a 6-OHDA-induced model of Parkinson's disease.
   Neuroscience. 2024 Jun 4:S0306-4522(24)00229.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

10. 
    Correction for Prusiner et al., Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Proc Natl Acad Sci U S A. 2024;121:e2408899121.
    PubMed        
    
    

    
    Rev Neurol (Paris)

11. HUTIN E, Poirier T, Meimoun M, Mardale V, et al
    Model-based cueing-as-needed for walking in Parkinson's disease: A randomized cross-over study.
    Rev Neurol (Paris). 2024 Jun 3:S0035-3787(24)00532.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.